Ammonium bituminosulfonate (ichthyol or ichthammol, CAS#8029-68-3 brand names: Albichthyol) is a product of natural origin obtained in the first step by dry distillation of sulfur-rich oil shale. It is used in medicine as a remedy for treating some forms of skin diseases, such as acne, eczema and psoriasis. It is commonly used in an ointment in 10% or 20% concentrate as a "drawing salve", but does not actually draw out foreign objects. It does however soften skin over the boil, allowing boil to come to a head sooner. It also decreases microorganisms in area of the boil. It is sometimes called "black ointment". Its dermatological action was discovered by German physician Paul Gerson Unna.
From elementary analysis its composition was calculated to be C28H36S5O6(NH4)2. However, as a product from natural origin it is a mixture of many different compounds.
Chemically, it is a sulfonated shale oil. It can be presented in two forms: pale sulfonated shale oil (PSSO), and dark sulfonated shale oil (DSSO). DSSO is also sometimes called ichthammol. The last form is a thick reddish brown liquid, possessing a bituminous odor and taste. It is soluble in water and miscible with glycerin, but is nearly insoluble in strong alcohol or concentrated ether. It contains a large percentage of organically combined sulfur. Ichthyol is incompatible with acids, alkali carbonates or hydrates and alkaloidal salts.
Pharmacologically, PSSO and DSSO have anti-inflammatory, bactericidal and fungicidal properties. In otology, a mixture of glycerol and ichthammol (G & I) has been used for generations for the topical treatment of ear infections. It is efficient against Gram-positive organisms. The anti-inflammatory action is explained by its influence on the formation, secretion and effect of inflammation mediators. DSSO is well tolerated and no indications of teratogenic, mutagenic or carcinogenic effects have been noted.
The European Medicines Agency recently published a Summary Report on ICHTHYOL-substances (synonym: bituminosulfonates) in course of the European Maximum Residue Limits (MRL) procedure (see report from June 2005) in veterinary medicine. The committee for Medicinal Products for Veterinary Use (CVMP) decided that because of good tolerance and safety there is no need to establish an MRL for ICHTHYOL-substances. As a result, ICHTHYOL-substances can be applied topically in all mammalian food producing species without restriction.
References
- Gayko G, Cholcha W, Kietzmann M (October 2000). "[Anti-inflammatory, antibacterial and antimycotic effects of dark sulfonated shale oil (ichthammol)]" (in German). Berl. Munch. Tierarztl. Wochenschr. 113 (10): 368–73. PMID 11084753.
- Cholcha W, Leuschner J, Leuschner F (July 1994). "[The adverse effects of dark sulfonated shale oil following local and systemic administration]" (in German). Arzneimittelforschung 44 (7): 844–9. PMID 7945520.
- Nilssen E, Wormald PJ, Oliver S (April 1996). "Glycerol and ichthammol: medicinal solution or mythical potion?". J Laryngol Otol 110 (4): 319–21. PMID 8733451.
- Diezel W, Schewe T, Rohde E, Rosenbach T, Czarnetzki BM (December 1992). "[Ammonium bituminosulfonate (Ichthyol). Anti-inflammatory effect and inhibition of the 5-lipoxygenase enzyme]" (in German). Hautarzt 43 (12): 772–4. PMID 1361926.
- Warnecke J, Wendt A (February 1998). "Anti-inflammatory action of pale sulfonated shale oil (ICHTHYOL pale) in UVB erythema test". Inflamm. Res. 47 (2): 75–8. doi:. PMID 9535545. http://link.springer-ny.com/link/service/journals/00011/bibs/8047002/80470075.htm.
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
